Atara Biotherapeutics
ATRA
ATRA
124 hedge funds and large institutions have $1.7B invested in Atara Biotherapeutics in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 60 increasing their positions, 29 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
124
Holders Change
+10
Holders Change %
+8.77%
% of All Funds
2.84%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
20
Increased
60
Reduced
29
Closed
10
Calls
$14.4M
Puts
$12M
Net Calls
+$2.39M
Net Calls Change
-$24.2M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$32.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$87.5M |
| 3 |
BlackRock
New York
|
$124M |
| 4 |
Wells Fargo
San Francisco,
California
|
$14.2M |
| 5 |
Goldman Sachs
New York
|
$15.5M |
Top Sellers
| 1 |
PC
PointState Capital
New York
|
$0 |
| 2 |
AG
Artal Group
Luxembourg
|
$36.8M |
| 3 |
Jennison Associates
New York
|
$0 |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
$46.2M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
$11.2M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
126
Jennison Associates
New York
| – | -$7.05M | -7,228 | Closed |
|
|
EMG
127
Ellington Management Group
Old Greenwich,
Connecticut
| – | -$1.62M | -1,664 | Closed |
|
|
TI
128
Trexquant Investment
Stamford,
Connecticut
| – | -$629K | -646 | Closed |
|
|
HP
129
Harbourvest Partners
Boston,
Massachusetts
| – | -$411K | -422 | Closed |
|
|
TRCT
130
Tower Research Capital (TRC)
New York
| – | -$213K | -219 | Closed |
|
131
SG Americas Securities
New York
| – | -$107K | -110 | Closed |
|
|
QT
132
Quantbot Technologies
New York
| – | -$22K | -23 | Closed |
|
|
APP
133
Avantax Planning Partners
Dubuque,
Iowa
| – | -$8K | -8 | Closed |
|
134
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$2K | -1 | Closed |
|